Pds Biotechnology Corp - On Aug. 6, approved reduction in force to align expenses with strategic priorities - SEC filing
P
PDSB• Workforce reduction and COO change disclosed in SEC filing
Aug. 25 (Reuters) - PDS Biotechnology Corp PDSB.O:
- PDS Biotechnology Corp - on Aug. 6, approved reduction in force to align expenses with strategic priorities - SEC filing
- PDS Biotechnology Corp - reduction in force to affect about 36% of workforce, completion expected in Q3 2026 - SEC filing
- PDS Biotechnology Corp - Stephan Toutain removed as chief operating officer effective Aug. 21, 2026 - SEC filing
Source text: []
Further company coverage: PDSB.O
